Dr. Ann Taylor is the newest member of Unlearn.AI’s Board of Directors. Dr. Taylor is the Chief Medical Officer at AstraZeneca and has spent more than 35 years as a leader in exploratory research and early clinical medicine.
At AstraZeneca, Dr. Taylor oversees safety and quality assurance, as well as risk assessment for medicines in development and in the market. She is also responsible for AstraZeneca’s global regulatory policy and intelligence. She has over 30 years of experience as a researcher, with a focus on Phase I and II clinical trial design and execution, including strategy, operations, and compliance.
This year will mark a pivotal moment at Unlearn for clinical research as they begin using Digital Twins to design and execute substantially more efficient clinical trials. It’s a critical step towards their goal of halving the time it takes to run a typical clinical trial. Dr. Taylor’s expertise across the lifecycle and ecosystem of drug development will help the team immensely on this journey. Clinical excellence, statistical rigor, and regulatory compliance are foundational principles at Unlearn, and Dr. Taylor is uniquely qualified to help Unlearn execute a strategy built on these pillars.